Mod­er­na finds a con­tract man­u­fac­tur­ing part­ner to scale up vac­cine sup­ply

Mod­er­na has been in­vest­ing heav­i­ly in its man­u­fac­tur­ing op­er­a­tions as CEO Stéphane Ban­cel ups es­ti­mates on how much Covid-19 vac­cine they can de­liv­er this year and next. Now, just a cou­ple of weeks af­ter promis­ing hun­dreds of mil­lions of dos­es to the US in a mat­ter of months, they’ve signed up a part­ner to help speed the man­u­fac­tur­ing work.

Con­tract man­u­fac­tur­ing out­fit Bax­ter Bio­Phar­ma So­lu­tions has signed on to pro­vide fill/fin­ish ster­ile man­u­fac­tur­ing ser­vices and sup­ply pack­ag­ing for 60-90 mil­lion dos­es of the Mod­er­na COVID-19 vac­cine this year. And Mod­er­na CTO Juan An­dres says the ex­tra help will as­sist the biotech in scal­ing up rapid­ly this year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER